- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Orthocell Ltd (OCC)
The Orthocell Ltd share price today is 0.590, view ASX OCC stock exchange data. Track the latest Orthocell Ltd share price with real-time updates on OCC stock performance including market cap, day range, 52-week range and dividend yield. Access OCC charts, earnings dates and analyst estimates to support your investment decisions.
Sydney
Currency in AUD
0.590
+0.015(+2.61%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.580
0.600
52 wk Range
0.490
1.160
OCC is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.5800.600
52 wk Range
0.4901.160
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
OCC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
0.900
Upside
+52.54%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock price often moves in the opposite direction of the market
Orthocell Ltd receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Orthocell Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 0.900
(+52.54% Upside)
Orthocell Ltd Earnings Call Summary for Q1/2027
- Orthocell reported $3.6M Q1 revenue with Remplir sales up 20% globally; U.S. unit sales rose 25% QoQ, but shares fell 8.33% to $0.55.
- Company holds AUD 39M cash, expects no additional funding needed; targeting breakeven at ~10,000 U.S. units or 6,000 procedures.
- U.S. distributor coverage reached 70% of population, ahead of 80% FY2027 target; repeat customers represent 80% of sales.
- Management expects 'significant and material revenue growth' ahead, citing first national IDN contract effective November and expanded distribution.
- Manufacturing capacity expanding from 100,000 to 350,000+ units annually; management claims business reached 'revenue inflection point.'
Last Updated: 22-10-2026, 06:30 am
Read Full TranscriptEarnings
Latest Release
21-10-2026
EPS / Forecast
-- / --
Revenue / Forecast
3.6M / --
Compare OCC to Peers and Sector
Metrics to compare | OCC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipOCCPeersSector | |
|---|---|---|---|---|
P/E Ratio | −11.3x | −4.1x | −0.2x | |
PEG Ratio | 0.30 | −0.02 | 0.00 | |
Price/Book | 4.6x | 2.8x | 2.6x | |
Price / LTM Sales | 13.7x | 10.6x | 2.8x | |
Upside (Analyst Target) | 52.5% | 318.6% | 60.9% | |
Fair Value Upside | Unlock | −7.6% | 9.5% | Unlock |
Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia and internationally. It offers Ortho Autologous Chondrocyte Implantation, a cartilage cell therapy for treatment of articular cartilage defects in the knee and ankle; OrthoATI, for treatment of chronic tendon injuries; Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental applications; and Remplir, a collagen scaffold used in peripheral nerve repair. The company also develops Collagen Medical Device platform products for bone, nerve, tendon, muscle, or scar tissue, and ligament repair; and Tendon Cell Therapy for rotator cuff and lateral epicondyle indications. Orthocell Limited was incorporated in 2006 and is headquartered in Murdoch, Australia.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Orthocell Ltd (OCC) Share Price Today?
The Orthocell Ltd share price today is 0.590.
What is the current Orthocell Ltd (OCC) share price and day range?
As of 09-11-2026, the Orthocell Ltd share price is 0.590, with a previous close of 0.590. The share price has ranged from 0.580 to 0.600 today, while the 52-week range spans from 0.490 to 1.160.
What Is the Orthocell Ltd Market Cap?
As of today, Orthocell Ltd market cap is 156.630M.
What Is the Orthocell Ltd (OCC) Share Price Target?
The average 12-month share price target for Orthocell Ltd is 0.900, with a high estimate of 1.15 and a low estimate of 0.65. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +52.54% Upside potential.
What Is Orthocell Ltd's Earnings Per Share (TTM)?
The Orthocell Ltd EPS (TTM) is -0.053.
From a Technical Analysis Perspective, Is OCC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
What Stock Exchange Does Orthocell Ltd Trade On?
Orthocell Ltd is listed and trades on the Sydney Stock Exchange.
What Is the Stock Symbol for Orthocell Ltd?
The stock symbol for Orthocell Ltd is "OCC."
How Many Times Has Orthocell Ltd Stock Split?
Orthocell Ltd has split 0 times.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.